IFP Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

IFP Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,000	Closed	-$27K	–	3524
2021 Q3	$27K	Buy	+8,000	New	+$24.7K	﹤0.01%	1861

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IFP Advisors's INFI Position: Q4 2021 in Review

IFP Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 8,000 shares — an estimated $27K sold.

IFP Advisors first reported a position in INFI in Q3 2021 and held it in 1 quarter. The position peaked at $27K in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

IFP Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
IFP Advisors sold 8,000 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $27K.
IFP Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
IFP Advisors's Infinity Pharmaceuticals, Inc. position peaked at $27K in Q3 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.